Cargando…
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620185/ http://dx.doi.org/10.1186/1129-2377-14-S1-P199 |
| _version_ | 1782265545413885952 |
|---|---|
| author | Aurora, SK Dodick, DW DeGryse, RE Turkel, CC |
| author_facet | Aurora, SK Dodick, DW DeGryse, RE Turkel, CC |
| author_sort | Aurora, SK |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3620185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Springer |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36201852013-09-20 OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT Aurora, SK Dodick, DW DeGryse, RE Turkel, CC J Headache Pain Poster Presentation Springer 2013 2013-02-21 /pmc/articles/PMC3620185/ http://dx.doi.org/10.1186/1129-2377-14-S1-P199 Text en Copyright ©2013 Aurora et al; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Aurora, SK Dodick, DW DeGryse, RE Turkel, CC OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title_full | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title_fullStr | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title_full_unstemmed | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title_short | OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT |
| title_sort | onabotulinumtoxina for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in preempt |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620185/ http://dx.doi.org/10.1186/1129-2377-14-S1-P199 |
| work_keys_str_mv | AT aurorask onabotulinumtoxinaforchronicmigraineefficacysafetyandtolerabilityinpatientswhoreceivedall5treatmentcyclesinpreempt AT dodickdw onabotulinumtoxinaforchronicmigraineefficacysafetyandtolerabilityinpatientswhoreceivedall5treatmentcyclesinpreempt AT degrysere onabotulinumtoxinaforchronicmigraineefficacysafetyandtolerabilityinpatientswhoreceivedall5treatmentcyclesinpreempt AT turkelcc onabotulinumtoxinaforchronicmigraineefficacysafetyandtolerabilityinpatientswhoreceivedall5treatmentcyclesinpreempt |